US Stock MarketDetailed Quotes
JAZZ Jazz Pharmaceuticals
- 108.130
- -0.880-0.81%
Trading Jul 22 11:09 ET
6.82BMarket Cap22.39P/E (TTM)
109.000High107.150Low70.23KVolume109.000Open109.010Pre Close7.56MTurnover0.12%Turnover Ratio17.73P/E (Static)63.06MShares146.70052wk High1.84P/B6.63BFloat Cap99.06052wk Low--Dividend TTM61.28MShs Float194.730Historical High--Div YieldTTM1.70%Amplitude0.515Historical Low107.706Avg Price1Lot Size
About Jazz Pharmaceuticals Company
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Company Profile
SymbolJAZZ
Company NameJazz Pharmaceuticals
Listing DateJun 1, 2007
Issue Price18.00
Founded2005
CEOMr. Bruce C. Cozadd
MarketNASDAQ
Employees2800
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressWaterloo Exchange,Waterloo Road,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-634-7800
Company Executives
- Name
- Position
- Salary
- Bruce C. Cozadd
- Chairman of the Board and Chief Executive Officer
- 15.34M
- Renee D. Gala
- President and Chief Operating Officer
- 5.43M
- Philip L. Johnson
- Executive Vice President and Chief Financial Officer
- --
- Patricia Carr
- Senior Vice President and Chief Accounting Officer
- 1.40M
- Neena M. Patil
- Executive Vice President and Chief Legal Officer
- 3.88M
- Samantha Pearce
- Senior Vice President, Europe and International
- --
- Liz Henderson
- Senior Vice President, Technical Operations
- --
- Dr. Robert Iannone, M.D.
- Executive Vice President and Global Head of Research and Development
- 4.98M
- Heather Ann McSharry
- Independent Director
- 543.77K
- Dr. Norbert G. Riedel,PhD
- Independent Director
- 533.77K
- Peter P. Gray
- Independent Director
- 533.77K
- Laura J. Hamill
- Independent Director
- --
- Anne O'Riordan
- Independent Director
- 523.77K
- Seamus C. Mulligan
- Independent Director
- 531.27K
- Patrick Thomas Kennedy
- Independent Director
- --
- Dr. Mark D. Smith, M.D.
- Independent Director
- 521.27K
- Jennifer E. Cook
- Independent Director
- 533.77K
- Patrick G. Enright
- Independent Director
- 526.27K
- Dr. Catherine Angell Sohn, Pharm.D.
- Independent Director
- 523.77K
- Kenneth W. O'Keefe
- Independent Director
- 513.77K
- Rick E. Winningham
- Lead Independent Director
- 571.27K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg